As computation is increasingly integrated into drug research and development, this Perspective analyzes company business models, funding and deals to provide unique insights into risks and opportunities in this quickly maturing industry, which aims to expedite the creation of life-saving therapeutics.
- Chloe Markey
- Samuel Croset
- Daniel Reker